Search

As the coronavirus correction rolls on, wise investors adapt,by selling weak stocks, holding cash and making smaller strategic investments in new opportunities.

Today, for our portfolio, that means selling two current holdings (one for a loss and one for a profit) and recommending a fast-growing medical company that has notonly a great growth story but also a chart that has been building a base for three months, setting up for its next advance.



Full details in the issue.

As we march toward spring it appears real-world risks are decreasing (more vaccines, lower case count, etc.) while the market risk for growth stocks has gone up (higher yields, volatility, etc.), at least in the short term.

As I scanned through dozens of charts and evaluated stories for this month’s addition my focus was repeatedly drawn to one stock. The chart is compelling, the story is enticing, and the recent Q4 report and forward guidance illustrate sound fundamentals, supported by long-term demand growth.



The stock appropriately balances the potential risks and rewards in the current market.



Enjoy!

Master limited partnerships, or MLPs, are a unique type of business allowed under the U.S. tax code.

Many income investors like municipal bonds for their tax advantages and yield. But the two experts below have some warnings about the sector. “I am frequently asked about municipal bonds and why I have not recommended them in this newsletter. The short answer is, I don’t like them. The longer answer...

For investors, the Almanac tells us that October is the start of the period of the year that has historically had the best performance in the stock market.

The Fed’s rate hikes are pressuring many stocks, but the higher rates are bullish for this regional bank ETF.